| Sanofi-Aventis (Suisse) SA - Dupixent 300 mg/ 2 ml, Injektionslösung im Fertigpen |
| 67661 | | 02 | | Dupixent 300 mg/ 2 ml | | Injektionslösung im Fertigpen | | D11AH05 | | Dupilumab | | 04.03.2021 | | |
|
| Composition |
| dupilumabum 300 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 0.45 mg. |
| Packungsbestandteile |
| solution injectable en stylo pré-rempli | | | | | | | | Principe actif | Concentr. |
|---|
| Dupilumabum | 300mg / 2ml |
| | BAG: Principe actif | Concentr. |
|---|
| Dupilumabum | 300 mg |
| | | | Agents auxilliaires |
|---|
| Acidum Aceticum Glaciale | | Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Natrii Acetas Trihydricus | | Polysorbatum 80 | | Saccharum |
| |
|
|
